Matisse Capital’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-11,315
| Closed | -$42K | – | 136 |
|
|
2018
Q1 | $42K | Sell |
11,315
-124,130
| -92% | -$461K | 0.03% | 128 |
|
|
2017
Q4 | $390K | Buy |
135,445
+18,500
| +16% | +$53.3K | 0.18% | 91 |
|
|
2017
Q3 | $525K | Buy |
116,945
+315
| +0.3% | +$1.41K | 0.25% | 70 |
|
|
2017
Q2 | $535K | Buy |
116,630
+91,200
| +359% | +$418K | 0.27% | 67 |
|
|
2017
Q1 | $107K | Buy |
25,430
+3,000
| +13% | +$12.6K | 0.06% | 105 |
|
|
2016
Q4 | $93K | Buy |
22,430
+10,500
| +88% | +$43.5K | 0.05% | 96 |
|
|
2016
Q3 | $97K | Buy |
+11,930
| New | +$97K | 0.05% | 97 |
|